Nothing Special   »   [go: up one dir, main page]

MX2017001714A - Rapid-release composition of cinitapride and simeticone and method for preparing same. - Google Patents

Rapid-release composition of cinitapride and simeticone and method for preparing same.

Info

Publication number
MX2017001714A
MX2017001714A MX2017001714A MX2017001714A MX2017001714A MX 2017001714 A MX2017001714 A MX 2017001714A MX 2017001714 A MX2017001714 A MX 2017001714A MX 2017001714 A MX2017001714 A MX 2017001714A MX 2017001714 A MX2017001714 A MX 2017001714A
Authority
MX
Mexico
Prior art keywords
simeticone
cinitapride
rapid
release composition
preparing same
Prior art date
Application number
MX2017001714A
Other languages
Spanish (es)
Inventor
Luis Lauria José
Original Assignee
Rhein Siegfried Sa De Cv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Rhein Siegfried Sa De Cv filed Critical Rhein Siegfried Sa De Cv
Priority to MX2017001714A priority Critical patent/MX2017001714A/en
Priority to CR20190402A priority patent/CR20190402A/en
Priority to BR112019015989-4A priority patent/BR112019015989A2/en
Priority to PE2019001412A priority patent/PE20191491A1/en
Priority to PCT/IB2018/050528 priority patent/WO2018146575A1/en
Priority to ARP180100282A priority patent/AR110797A1/en
Publication of MX2017001714A publication Critical patent/MX2017001714A/en
Priority to CL2019001944A priority patent/CL2019001944A1/en
Priority to ECSENADI201951198A priority patent/ECSP19051198A/en
Priority to DO2019000190A priority patent/DOP2019000190A/en
Priority to CONC2019/0008347A priority patent/CO2019008347A2/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
    • A61K31/166—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide having the carbon of a carboxamide group directly attached to the aromatic ring, e.g. procainamide, procarbazine, metoclopramide, labetalol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/695—Silicon compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/14—Esters of carboxylic acids, e.g. fatty acid monoglycerides, medium-chain triglycerides, parabens or PEG fatty acid esters
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

The present invention relates to an orally-administered pharmaceutical composition, in the form of capsules with liquid content, which comprises a fixed-dose combination of cinitapride tartrate and simeticone together with at least one surfactant and, optionally, one or more pharmaceutically acceptable excipients, and to the method for obtaining said composition.
MX2017001714A 2017-02-07 2017-02-07 Rapid-release composition of cinitapride and simeticone and method for preparing same. MX2017001714A (en)

Priority Applications (10)

Application Number Priority Date Filing Date Title
MX2017001714A MX2017001714A (en) 2017-02-07 2017-02-07 Rapid-release composition of cinitapride and simeticone and method for preparing same.
CR20190402A CR20190402A (en) 2017-02-07 2018-01-29 Rapid-release composition of cinitapride and simeticone and method for preparing same
BR112019015989-4A BR112019015989A2 (en) 2017-02-07 2018-01-29 COMPOSITION OF QUICK RELEASE OF CINITAPRIDE AND SIMETICONE AND PROCESS TO PREPARE THE SAME
PE2019001412A PE20191491A1 (en) 2017-02-07 2018-01-29 QUICK RELEASE COMPOSITION OF CINITAPRIDE AND SYMETICONE AND PROCESS TO PREPARE IT
PCT/IB2018/050528 WO2018146575A1 (en) 2017-02-07 2018-01-29 Rapid-release composition of cinitapride and simeticone and method for preparing same
ARP180100282A AR110797A1 (en) 2017-02-07 2018-02-06 COMPOSITION OF QUICK RELEASE OF CINITAPRIDA AND SIMETICONE AND PROCESS TO PREPARE IT
CL2019001944A CL2019001944A1 (en) 2017-02-07 2019-07-11 Rapid release cinitapride and simethicone composition and process for preparing it.
ECSENADI201951198A ECSP19051198A (en) 2017-02-07 2019-07-16 QUICK RELEASE COMPOSITION OF CINITAPRIDA AND SYMETICONE AND PROCESS TO PREPARE IT
DO2019000190A DOP2019000190A (en) 2017-02-07 2019-07-19 QUICK RELEASE COMPOSITION OF CINITAPRIDA AND SYMETICONE AND PROCESS TO PREPARE IT.
CONC2019/0008347A CO2019008347A2 (en) 2017-02-07 2019-07-30 Quick release composition of cinitapride and simethicone and process to prepare it

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
MX2017001714A MX2017001714A (en) 2017-02-07 2017-02-07 Rapid-release composition of cinitapride and simeticone and method for preparing same.

Publications (1)

Publication Number Publication Date
MX2017001714A true MX2017001714A (en) 2018-08-06

Family

ID=63108046

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2017001714A MX2017001714A (en) 2017-02-07 2017-02-07 Rapid-release composition of cinitapride and simeticone and method for preparing same.

Country Status (10)

Country Link
AR (1) AR110797A1 (en)
BR (1) BR112019015989A2 (en)
CL (1) CL2019001944A1 (en)
CO (1) CO2019008347A2 (en)
CR (1) CR20190402A (en)
DO (1) DOP2019000190A (en)
EC (1) ECSP19051198A (en)
MX (1) MX2017001714A (en)
PE (1) PE20191491A1 (en)
WO (1) WO2018146575A1 (en)

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6676933B2 (en) * 2001-05-23 2004-01-13 Osmotica Corp. Pharmaceutical composition containing mosapride and pancreatin
EP1596838A2 (en) * 2003-02-11 2005-11-23 Torrent Pharmaceuticals Ltd Once a day orally administered pharmaceutical compositions comprising a proton pump inhibitor and a prokinetic agent
CN101065115A (en) * 2004-11-24 2007-10-31 默克公司 Liquid and semi-solid pharmaceutical formulations for oral administration of a substituted amide
WO2009066146A2 (en) * 2007-11-19 2009-05-28 Cadila Pharmaceuticals Ltd. Stable solutions of sparingly soluble actives

Also Published As

Publication number Publication date
AR110797A1 (en) 2019-05-02
PE20191491A1 (en) 2019-10-21
ECSP19051198A (en) 2019-07-31
CL2019001944A1 (en) 2019-12-06
CO2019008347A2 (en) 2019-08-30
CR20190402A (en) 2019-09-20
DOP2019000190A (en) 2019-10-15
BR112019015989A2 (en) 2020-03-31
WO2018146575A1 (en) 2018-08-16

Similar Documents

Publication Publication Date Title
PH12017502431A1 (en) Pharmaceutical formulations comprising tenofovir and emtrictabine
PH12016501841A1 (en) Immunosuppressant formulation
EP3706774A4 (en) Glp-2 analogs and peptibodies for administration before during, or after surgery
WO2017037594A3 (en) Pharmaceutical composition used for reducing localised fat and use of pharmaceutical composition
PH12016501825B1 (en) Amorphous solid dispersion comprising taxane, tablet comprising the same, and method for preparing the same
PH12017501084A1 (en) Insulin glargine/lixisenatide fixed ratio formulation
CA2863376A1 (en) Gastroretentive tablets
IN2014MU01042A (en)
PH12015500165A1 (en) Formulations and methods of manufacturing formulations for use in colonic evacuation
EP3616685A4 (en) Method for determining authenticity of pharmaceutical composition for oral administration, pharmaceutical composition for oral administration, and system for determining authenticity of pharmaceutical composition for oral administration
IL273704A (en) Bi-layer pharmaceutical tablet formulation
EP3648745A4 (en) Pharmaceutical composition including multi-unit spheroidal tablet containing esomeprazole and spheroidal pharmaceutically acceptable salt thereof, and method of preparing the pharmaceutical composition
MX2019001771A (en) Solid pharmaceutical composition comprising amorphous sofosbuvir.
MX2017001714A (en) Rapid-release composition of cinitapride and simeticone and method for preparing same.
MX2015003956A (en) Pharmaceutical composition comprising micronized pinaverium bromide and simeticone.
MX2018005345A (en) Pharmaceutical compositions of dimethyl fumarate.
IN2013MU03370A (en)
IN2014MU00043A (en)
EA201991007A1 (en) SOLID PHARMACEUTICAL COMPOSITIONS BASED ON LURAZIDONE HYDROCHLORIDE FOR ORAL USE
MX2019005005A (en) Extended release tablet comprising a weight-loss drug.
WO2016108507A3 (en) Composite tablet for oral administration comprising melatonin and sertraline
MX2016016587A (en) Improved composition of lansoprazole and simeticone and method for preparing same.
PH12018501392A1 (en) Pharmaceutical composite preparation
EP3661486A4 (en) Pharmaceutical composition comprising tetrofosmin and pharmaceutically acceptable salts thereof
TR201720510A2 (en) ORALLY DISINTEGRATING TABLET FORMULATIONS OF IVABRADINE